Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alessandra Trianni"'
Autor:
Elena Ivanova Reipold, Philippa Easterbrook, Alessandra Trianni, Nivedha Panneer, Douglas Krakower, Stefano Ongarello, Teri Roberts, Veronica Miller, Claudia Denkinger
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss S1, Pp 159-175 (2017)
Abstract Background The current low access to virological testing to confirm chronic viraemic HCV infection in low- and middle-income countries (LMIC) is limiting the rollout of hepatitis C (HCV) care. Existing tests are complex, costly and require s
Externí odkaz:
https://doaj.org/article/487cfa76c83447308580245d0decdd36
Autor:
Elena Ivanova Reipold, Alessandra Trianni, Douglas Krakower, Stefano Ongarello, Teri Roberts, Philippa Easterbrook, Claudia Denkinger
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss S1, Pp 149-157 (2017)
Abstract Background Access to hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnostics remains a key bottleneck in scale-up of access to HBV and HCV treatment, particularly in low- and middle-income countries (LMICs) that lack laboratory resou
Externí odkaz:
https://doaj.org/article/7bc34d85567a488fabe7fa3c0a49f2ab
Publikováno v:
Rivista di psichiatria. 57(3)
Complex dissociative disorders (CDD) include dissociative identity disorder (DID) and the most common other specified dissociative disorder (OSDD, type 1). While consensus-based treatments for CDD are lacking in several international guidelines, pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7893d3fb1d735556a68fa9faac803ba7
https://pubmed.ncbi.nlm.nih.gov/35695685
https://pubmed.ncbi.nlm.nih.gov/35695685
Autor:
Veronica Miller, Teri Roberts, Stefano Ongarello, Alessandra Trianni, Douglas S. Krakower, Nivedha Panneer, Claudia M. Denkinger, Philippa Easterbrook, Elena Ivanova Reipold
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss S1, Pp 159-175 (2017)
BMC Infectious Diseases
BMC Infectious Diseases
Background The current low access to virological testing to confirm chronic viraemic HCV infection in low- and middle-income countries (LMIC) is limiting the rollout of hepatitis C (HCV) care. Existing tests are complex, costly and require sophistica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd49346e6b83e157bfa80894fde4a6de
http://link.springer.com/article/10.1186/s12879-017-2770-5
http://link.springer.com/article/10.1186/s12879-017-2770-5
Autor:
Teri Roberts, Philippa Easterbrook, Douglas S. Krakower, Elena Ivanova Reipold, Claudia M. Denkinger, Alessandra Trianni, Stefano Ongarello
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 17, Iss S1, Pp 149-157 (2017)
BMC Infectious Diseases, Vol 17, Iss S1, Pp 149-157 (2017)
Background Access to hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnostics remains a key bottleneck in scale-up of access to HBV and HCV treatment, particularly in low- and middle-income countries (LMICs) that lack laboratory resources and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39268d30b5e46d52b80cb7e95de9262
http://europepmc.org/articles/PMC5688454
http://europepmc.org/articles/PMC5688454